Laboratoire d'Hématologie Moléculaire et Cellulaire (LR16IPT07), Institut Pasteur de Tunis, Tunis, Tunisie,
Faculté des Sciences de Tunis, Université de Tunis El Manar, Tunis, Tunisie.
Cell Physiol Biochem. 2021 Mar 6;55(1):117-129. doi: 10.33594/000000333.
BACKGROUND/AIMS: Hereditary Spherocytosis (HS) is the most common erythrocyte membrane disorder causing hemolytic anemia. The wide heterogeneity of both clinical and laboratory manifestations of HS contributes to difficulties associated with the diagnosis of this disorder. Although massive data previously reported worldwide, there is yet no data on HS among the Tunisian population. Here we aim to characterize HS in Tunisian patients at biochemical and cellular levels, identify the membrane protein deficiency, and compare the accuracy of the diagnostic tests to identify the most appropriate assay for HS diagnosis.
We investigated 81 patients with hemolytic anemia and 167 normal controls. The exploration of HS based on clinical and family history, physical examination, and the results of laboratory tests: blood smear, osmotic fragility test (OFT), cryohemolysis test (CT), pink test (PT), eosine-5'-maleimide (EMA) test, and erythrocyte membrane protein electrophoresis.
We identified 21 patients with HS, classified as severe (6/21;28.5%), moderate (10/21;47.6%), and mild (5/21;23.8%). The most prevalent protein deficiency was the band 3 protein detected in ten Tunisian HS patients. The EMA test showed a high specificity (97.5%) and sensitivity (94.7%) for HS diagnosis compared to the other screening tests. Interestingly, fourteen among sixteen patients presenting with homozygous sickle cells HbSS showed an increase of EMA fluorescence intensity compared to other anemic patients.
Our study highlights the efficiency of the EMA dye for the detection of HS whatever the nature of the involved protein deficiency. We report for the first time, the most prevalent protein deficiency among Tunisians with HS. Moreover, we found that the combination of the EMA-binding test with PT or incubated OFT improves the diagnosis sensitivity while maintaining a good specificity.
背景/目的:遗传性球形红细胞增多症(HS)是最常见的红细胞膜异常疾病,导致溶血性贫血。HS 的临床表现和实验室表现存在广泛的异质性,这给该疾病的诊断带来了困难。尽管以前在全球范围内有大量数据报道,但在突尼斯人群中尚无 HS 的相关数据。在此,我们旨在从生化和细胞水平上对突尼斯患者的 HS 进行特征描述,确定膜蛋白缺陷,并比较诊断试验的准确性,以确定最适合 HS 诊断的检测方法。
我们调查了 81 名溶血性贫血患者和 167 名正常对照者。通过临床和家族史、体格检查以及实验室检查结果(血涂片、渗透脆性试验(OFT)、冷溶血试验(CT)、粉红试验(PT)、伊文思蓝-5'-马来酰亚胺(EMA)试验和红细胞膜蛋白电泳)来探索 HS。
我们确定了 21 名 HS 患者,分为严重(6/21;28.5%)、中度(10/21;47.6%)和轻度(5/21;23.8%)。最常见的蛋白缺陷是在 10 名突尼斯 HS 患者中检测到的带 3 蛋白。与其他筛选试验相比,EMA 试验对 HS 诊断具有较高的特异性(97.5%)和敏感性(94.7%)。有趣的是,在 16 名患有纯合镰状细胞病 HbSS 的患者中,有 14 名患者的 EMA 荧光强度比其他贫血患者增加。
我们的研究强调了 EMA 染料在检测 HS 方面的效率,无论涉及的蛋白缺陷性质如何。我们首次报道了突尼斯 HS 患者中最常见的蛋白缺陷。此外,我们发现将 EMA 结合试验与 PT 或孵育 OFT 相结合可以提高诊断敏感性,同时保持良好的特异性。